在1型糖尿病中,β细胞与δ细胞电气合的丧失是导致低血糖引起的葡萄糖分泌障碍的基础
Thomas G Hill1, Rui Gao1, Anna Benrick2
1Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Nature metabolism
|September 23, 2024
概括
在1型糖尿病中,缺乏对低葡萄糖的葡萄糖激素反应是由于过度的索马托斯塔丁. 这种受损的反调节会增加1型糖尿病患者的低血糖风险.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病研究 糖尿病研究
- 细胞生理学 细胞生理学
背景情况:
- 1型糖尿病 (T1D) 的特征是胰岛素和葡萄糖分泌受损.
- 患有T1D的患者往往缺乏对血葡萄糖下降的逆调节性葡萄糖反应,从而增加低血糖的风险.
- 之前在动物上的研究表明,SSTR抗体可以恢复葡萄糖分泌,但人类的相关性尚不清楚.
研究的目的:
- 研究人类T1D小岛中葡萄糖分泌受损背后的细胞机制.
- 为了确定低葡萄糖对葡萄糖反应的缺陷是否保留在人类T1D中.
- 阐明 somatostatin 在 T1D 中对抗调节的丧失中的作用.
主要方法:
- 从T1D捐赠者和非肥胖糖尿病小鼠中分离出来的人类小岛被使用.
- 测量了对低葡萄糖的反应中的葡萄糖分泌.
- 研究了体静止素和细胞间通信 (间隙结) 的作用.
主要成果:
- 人类T1D岛屿,就像T1D小鼠的岛屿一样,在低葡萄糖的情况下未能刺激葡萄糖分泌.
- 这种缺陷与体静止素的高分泌有关,导致对膜抑制葡萄糖释放.
- "电动车"机制,即β细胞的高极化通常会抑制体静止素,由于β细胞的破坏而丧失.
结论:
- 在T1D中,自免疫性β细胞的破坏破坏了正常抑制体静止素分泌的过程.
- 这导致过量的体静止素,损害了葡萄糖的逆调节,增加了低血糖的风险.
- 剩余的β细胞功能可能对维持反调节反应和减少低血糖症的严重性至关重要.
更多相关视频
12:33A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
65.2K
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
1.3K
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Hypoglycemia and Glucagon
207
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
207
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Pathophysiology of Diabetes
900
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
900
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
